Skip to main content

Table 5 Sensitivity of the MDASI-MM to change in ECOG PS ( n = 126)

From: Validation of the M. D. Anderson Symptom Inventory multiple myeloma module

 

Stable/improving ECOG PS (n= 60)

Worsening ECOG PS (n= 66)

Difference

Effect size

 

Meana

SD

Meana

SD

  

Change in composite scores

 Core subscale

0.07

1.54

1.66

1.62

1.59b

0.90

 Severity subscale

0.09

1.35

1.52

1.42

1.43b

0.91

 Interference subscale

0.16

2.63

2.15

2.38

1.99b

0.74

Change in MDASI-MM items

 Dry mouth

−0.92

3.49

3.44

3.33

4.36b

1.08

 Fatigue

−0.28

3.11

2.44

2.68

2.72b

0.85

 Lack of appetite

0.70

3.09

3.85

3.62

3.15b

0.85

 Nausea

0.68

2.25

3.48

3.60

2.80b

0.84

 Drowsiness

−0.52

3.92

2.23

2.92

2.75b

0.74

 Diarrhea

1.15

3.01

3.68

3.67

2.53b

0.71

 Vomiting

0.40

1.43

1.89

3.10

1.49c

0.59

 Mouth/throat sores

0.37

2.18

1.86

3.41

1.49c

0.50

 Pain

−0.48

3.35

1.15

3.09

1.63c

0.49

 Muscle weakness

0.42

3.29

1.83

2.52

1.41c

0.47

 Numbness

0.90

2.70

−0.24

2.21

−1.14c

0.45

 Disturbed sleep

0.02

3.41

1.20

3.21

1.18c

0.35

 Bone aches

−1.03

3.59

0.13

3.17

1.16c

0.34

 Shortness of breath

−0.08

2.23

0.68

2.23

0.76

0.34

 Sadness

−0.02

2.00

0.55

2.77

0.57

0.23

 Difficulty paying attention

0.25

1.87

0.65

2.12

0.40

0.20

 Difficulty remembering

0.02

1.78

0.27

1.62

0.25

0.15

 Constipation

−0.50

2.94

−0.20

2.24

0.30

0.11

 Distress

0.52

2.66

0.68

2.97

0.16

0.06

 Rash

0.32

1.58

0.34

2.16

0.02

0.01

  1. a A positive mean indicates increased symptom intensity; negative indicates decreased symptom intensity.
  2. b Significant at P < .001.
  3. c Significant at P < .05.